ATE382053T1 - System zur antikörperexpression und- synthese - Google Patents
System zur antikörperexpression und- syntheseInfo
- Publication number
- ATE382053T1 ATE382053T1 AT02763536T AT02763536T ATE382053T1 AT E382053 T1 ATE382053 T1 AT E382053T1 AT 02763536 T AT02763536 T AT 02763536T AT 02763536 T AT02763536 T AT 02763536T AT E382053 T1 ATE382053 T1 AT E382053T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- antibodies
- synthesis
- systems
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31520901P | 2001-08-27 | 2001-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE382053T1 true ATE382053T1 (de) | 2008-01-15 |
Family
ID=23223369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02763536T ATE382053T1 (de) | 2001-08-27 | 2002-08-26 | System zur antikörperexpression und- synthese |
Country Status (11)
Country | Link |
---|---|
US (6) | US20030077739A1 (de) |
EP (1) | EP1427744B1 (de) |
JP (1) | JP4461210B2 (de) |
KR (1) | KR100968664B1 (de) |
CN (1) | CN100513414C (de) |
AT (1) | ATE382053T1 (de) |
CA (1) | CA2454731C (de) |
DE (1) | DE60224291T2 (de) |
MX (1) | MXPA04001566A (de) |
NZ (1) | NZ530852A (de) |
WO (1) | WO2003018771A2 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009618A2 (en) | 2002-07-18 | 2004-01-29 | Crucell Holland B.V. | Recombinant production of mixtures of antibodies |
US6979556B2 (en) * | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
ATE382053T1 (de) * | 2001-08-27 | 2008-01-15 | Genentech Inc | System zur antikörperexpression und- synthese |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
WO2004065417A2 (en) | 2003-01-23 | 2004-08-05 | Genentech, Inc. | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
US7605235B2 (en) | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
US9708410B2 (en) | 2003-05-30 | 2017-07-18 | Janssen Biotech, Inc. | Anti-tissue factor antibodies and compositions |
CA2527694C (en) | 2003-05-30 | 2015-07-14 | Hendricus Renerus Jacobus Mattheus Hoogenboom | Fab library for the preparation of anti vegf and anti rabies virus fabs |
KR100570422B1 (ko) * | 2003-10-16 | 2006-04-11 | 한미약품 주식회사 | 대장균 분비서열을 이용하여 항체 단편을 분비·생산하는 발현벡터 및 이를 이용하여 항체 단편을 대량 생산하는 방법 |
CN100475965C (zh) * | 2005-07-22 | 2009-04-08 | 上海高科联合生物技术研发有限公司 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
WO2009021548A1 (en) * | 2007-08-10 | 2009-02-19 | Wacker Chemie Ag | Expression of full length igg and secretion into the culture medium of prokaryotic cells |
JP2011514161A (ja) * | 2008-02-29 | 2011-05-06 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | 免疫グロブリン組成物およびその製造方法 |
JP5463528B2 (ja) * | 2009-02-25 | 2014-04-09 | 味の素株式会社 | L−システイン生産菌及びl−システインの製造法 |
JP6132551B2 (ja) | 2009-09-24 | 2017-05-24 | ユセベ ファルマ ソシエテ アノニム | シャペロン活性を保持するプロテアーゼ欠損DegP並びにノックアウトTsp及びptr遺伝子を持つ、組換えタンパク質発現のための細菌株 |
EP2496601B1 (de) * | 2009-11-05 | 2017-06-07 | F. Hoffmann-La Roche AG | Methoden und zusammensetzung zur sekretion heterologer polypeptide |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000588D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
US8722044B2 (en) | 2011-03-15 | 2014-05-13 | Janssen Biotech, Inc. | Human tissue factor antibody and uses thereof |
EP2692911B1 (de) | 2011-03-31 | 2017-02-22 | Kunimine Industries Co., Ltd. | Gebrauch eines mittels zum suchen nach proteinkristallisationsbedingungen und verfahren zum suchen nach proteinkristallisationsbedingungen |
LT2731973T (lt) | 2011-07-13 | 2018-02-26 | Ucb Biopharma Sprl | Bakterijų padermė, ekspresuojanti rekombinantinį dsbc |
KR20230091201A (ko) | 2012-04-20 | 2023-06-22 | 메뤼스 엔.페. | Ig-유사 분자의 제조방법 및 제조수단 |
GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
CA2877009C (en) * | 2012-07-05 | 2023-10-03 | Devin TESAR | Expression and secretion system |
DK3187586T3 (da) * | 2012-08-05 | 2019-10-14 | Absci Llc | Inducerbar co-ekspressionssystem |
US20150353940A1 (en) * | 2013-08-05 | 2015-12-10 | Absci, Llc | Vectors for use in an inducible coexpression system |
CN103468735B (zh) * | 2013-09-18 | 2016-01-20 | 山西大学 | 重组华溪蟹金属硫蛋白(rcMT)及其单克隆抗体的制备 |
US10435694B2 (en) | 2014-03-14 | 2019-10-08 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
BR112016021383A2 (pt) | 2014-03-24 | 2017-10-03 | Genentech Inc | Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo |
KR102307278B1 (ko) | 2014-04-29 | 2021-09-30 | 노파르티스 아게 | 신규 척추동물 세포 및 관심 폴리펩티드의 재조합적 발현 방법 |
SI3164492T1 (sl) * | 2014-07-03 | 2020-02-28 | F. Hoffmann-La Roche Ag | Sistem polipeptidne ekspresije |
EP3167065B1 (de) | 2014-07-09 | 2020-03-25 | Lupin Limited | Duales system zur cistronischen bakteriellen expression |
US10066002B2 (en) * | 2014-11-05 | 2018-09-04 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
CA2966558C (en) | 2014-11-05 | 2024-03-12 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
CN105505884B (zh) * | 2016-01-26 | 2017-10-03 | 郑州师范学院 | 进行抗体表达和组装的重组系统及应用 |
CN111032850A (zh) | 2017-04-27 | 2020-04-17 | 朱诺治疗学有限公司 | 寡聚粒子试剂及其使用方法 |
WO2019038338A1 (en) | 2017-08-23 | 2019-02-28 | Sandoz Ag | PROTEIN EXPRESSION SYSTEM WITH MULTIPLE GENIC COPIES |
WO2019120635A1 (en) | 2017-12-18 | 2019-06-27 | Ventana Medical Systems, Inc. | Peptide nucleic acid conjugates |
MX2020008470A (es) * | 2018-02-14 | 2020-09-25 | Generation Bio Co | Vectores de adn no virales y usos de estos para la produccion de anticuerpos y proteinas de fusion. |
TW202031899A (zh) * | 2018-11-05 | 2020-09-01 | 美商建南德克公司 | 在原核宿主細胞中產生二鏈蛋白質之方法 |
US11352445B2 (en) * | 2018-12-31 | 2022-06-07 | Jecho Laboratories Inc. | Method for preparing recombinant protein from bacterium and composition containing the same |
CA3124515A1 (en) * | 2019-01-23 | 2020-07-30 | Genentech, Inc. | Methods of producing multimeric proteins in eukaryotic host cells |
AU2020243460A1 (en) | 2019-03-18 | 2021-10-07 | Bio-Rad Abd Serotec Gmbh | Protection of SpyTag-containing periplasmic fusion proteins from protease Tsp and ompT degradation |
SE544001C2 (en) * | 2020-03-17 | 2021-10-26 | Xbrane Biopharma Ab | Novel combination of tis sequences, signal peptide sequences and nucleic acid sequences encoding heavy and light chains of an antibody |
SE544000C2 (en) * | 2020-03-17 | 2021-10-26 | Xbrane Biopharma Ab | Novel combination of tis sequence, signal peptide sequence and nucleic acid sequence encoding a recombinant protein |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE30985E (en) * | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
US4560655A (en) * | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4767704A (en) * | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
IL85035A0 (en) * | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
EP0307434B2 (de) * | 1987-03-18 | 1998-07-29 | Scotgen Biopharmaceuticals, Inc. | Geänderte antikörper |
CA1341235C (en) | 1987-07-24 | 2001-05-22 | Randy R. Robinson | Modular assembly of antibody genes, antibodies prepared thereby and use |
DE3744595A1 (de) * | 1987-12-31 | 1989-07-13 | Andreas Dr Plueckthun | Verfahren zur gentechnischen herstellung von antikoerpern |
AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
EP0401384B1 (de) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemisch modifizierte granulocytenkolonie erregender faktor |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US5208020A (en) * | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5508192A (en) * | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
US5264365A (en) * | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
EP0580737B1 (de) * | 1991-04-10 | 2004-06-16 | The Scripps Research Institute | Bibliotheken heterodimerer rezeptoren mittels phagemiden |
JP4124480B2 (ja) * | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
JP3951062B2 (ja) * | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、2官能性F(ab’)2抗体の産生のための使用 |
WO1993008300A1 (en) | 1991-10-18 | 1993-04-29 | The University Of Calgary | Expression-secretion vectors for the production of biologically active fv fragments |
US20020037558A1 (en) | 1991-10-23 | 2002-03-28 | Kin-Ming Lo | E.coli produced immunoglobulin constructs |
EP0617706B1 (de) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalente antigen-bindende proteine |
DE69332948T2 (de) | 1992-03-05 | 2003-11-27 | Univ Texas | Verwendung von Immunokonjugate zur Diagnose und/oder Therapie der vaskularisierten Tumoren |
GB9206422D0 (en) | 1992-03-24 | 1992-05-06 | Bolt Sarah L | Antibody preparation |
GB9215541D0 (en) * | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
FR2715664B1 (fr) * | 1994-01-31 | 1996-04-12 | Proteine Performance Sa | Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux. |
FR2724182B1 (fr) * | 1994-09-02 | 1996-12-13 | Pasteur Institut | Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations |
US5639635A (en) | 1994-11-03 | 1997-06-17 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) * | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5747662A (en) * | 1995-03-01 | 1998-05-05 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5641870A (en) * | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
DE19513676A1 (de) * | 1995-04-11 | 1996-10-17 | Behringwerke Ag | Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragmentfusionsmolekülen in E.coli |
WO1997038123A1 (en) * | 1996-04-05 | 1997-10-16 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
GB9614700D0 (en) | 1996-07-12 | 1996-09-04 | Medical Res Council | Over-expression of proteins in E.Coli |
WO1998049198A1 (en) | 1997-04-30 | 1998-11-05 | Enzon, Inc. | Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
DK0999853T3 (da) | 1997-06-13 | 2003-04-22 | Genentech Inc | Stabiliseret antostofformulering |
US6171586B1 (en) * | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
EP1025246A1 (de) * | 1997-10-23 | 2000-08-09 | Plückthun, Andreas, Prof. Dr. | Verfahren zur identifizierung von nukleinsäureseqeunzen und (poly)peptide die die funktionelle periplasmatische proteinexpression erhöhen |
EP1068241B1 (de) | 1998-04-02 | 2007-10-10 | Genentech, Inc. | Antikörper varianten und fragmente davon |
WO2000024873A1 (en) * | 1998-10-28 | 2000-05-04 | Genentech, Inc. | Process for recovering heterologous polypeptides from bacterial cells |
US6208020B1 (en) * | 1999-02-24 | 2001-03-27 | Matsushita Electronics Corporation | Leadframe for use in manufacturing a resin-molded semiconductor device |
DE60025829T2 (de) * | 1999-07-12 | 2006-11-02 | Genentech, Inc., South San Francisco | Expressionsvektoren und anwendungsmethoden |
US20050005310A1 (en) * | 1999-07-12 | 2005-01-06 | Genentech, Inc. | Expression vectors and methods |
EP1077263A1 (de) * | 1999-07-29 | 2001-02-21 | F.Hoffmann-La Roche Ag | Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen |
US6703494B2 (en) * | 2000-03-16 | 2004-03-09 | Genentech, Inc. | Anti-tissue factor antibodies with enhanced anticoagulant potency |
MXPA03001645A (es) * | 2000-08-24 | 2004-05-14 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
DE60117601T2 (de) * | 2000-12-14 | 2006-11-16 | Genentech Inc., San Francisco | Bakterielle wirtstämme |
DK1356052T3 (da) * | 2000-12-14 | 2008-12-08 | Genentech Inc | Produktion af hele antistoffer i prokaryotiske celler |
US6979556B2 (en) * | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
ATE382053T1 (de) * | 2001-08-27 | 2008-01-15 | Genentech Inc | System zur antikörperexpression und- synthese |
-
2002
- 2002-08-26 AT AT02763536T patent/ATE382053T1/de active
- 2002-08-26 DE DE60224291T patent/DE60224291T2/de not_active Expired - Lifetime
- 2002-08-26 JP JP2003523622A patent/JP4461210B2/ja not_active Expired - Lifetime
- 2002-08-26 CA CA2454731A patent/CA2454731C/en not_active Expired - Lifetime
- 2002-08-26 US US10/227,694 patent/US20030077739A1/en not_active Abandoned
- 2002-08-26 KR KR1020047002856A patent/KR100968664B1/ko active IP Right Grant
- 2002-08-26 MX MXPA04001566A patent/MXPA04001566A/es active IP Right Grant
- 2002-08-26 NZ NZ530852A patent/NZ530852A/en not_active IP Right Cessation
- 2002-08-26 WO PCT/US2002/027220 patent/WO2003018771A2/en active IP Right Grant
- 2002-08-26 CN CNB028168879A patent/CN100513414C/zh not_active Expired - Lifetime
- 2002-08-26 EP EP02763536A patent/EP1427744B1/de not_active Expired - Lifetime
-
2006
- 2006-02-09 US US11/351,886 patent/US20060246542A1/en not_active Abandoned
- 2006-05-22 US US11/438,484 patent/US20070015244A1/en not_active Abandoned
-
2007
- 2007-01-25 US US11/627,071 patent/US20070224664A1/en not_active Abandoned
-
2011
- 2011-02-23 US US13/033,521 patent/US20110244517A1/en not_active Abandoned
-
2013
- 2013-09-05 US US14/019,399 patent/US9688775B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2003018771A2 (en) | 2003-03-06 |
US20030077739A1 (en) | 2003-04-24 |
CN1549821A (zh) | 2004-11-24 |
US20060246542A1 (en) | 2006-11-02 |
WO2003018771A3 (en) | 2004-03-11 |
KR100968664B1 (ko) | 2010-07-06 |
US20110244517A1 (en) | 2011-10-06 |
US9688775B2 (en) | 2017-06-27 |
US20070015244A1 (en) | 2007-01-18 |
CA2454731A1 (en) | 2003-03-06 |
EP1427744A2 (de) | 2004-06-16 |
CA2454731C (en) | 2010-11-02 |
JP2005517385A (ja) | 2005-06-16 |
US20070224664A1 (en) | 2007-09-27 |
EP1427744B1 (de) | 2007-12-26 |
EP1427744A4 (de) | 2005-12-07 |
DE60224291D1 (de) | 2008-02-07 |
NZ530852A (en) | 2006-11-30 |
MXPA04001566A (es) | 2004-05-17 |
US20140120580A1 (en) | 2014-05-01 |
DE60224291T2 (de) | 2008-12-11 |
CN100513414C (zh) | 2009-07-15 |
KR20040031011A (ko) | 2004-04-09 |
JP4461210B2 (ja) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE382053T1 (de) | System zur antikörperexpression und- synthese | |
ATE405650T1 (de) | Produktion von ganzen antikörpern in prokaryontischen zellen | |
CY1119127T1 (el) | Επιτοποι σκληροστινης | |
IL172854A0 (en) | Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations | |
EA201000424A1 (ru) | Антитела к il-23 | |
WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
ECSP105739A (es) | Anticuerpos de neutralización contra gdf-8 | |
BRPI0513135A (pt) | bibliotecas de polinucleotìdeos, método de produção das mesmas, método de identificação de um polinucleotìdeo, região de ligação, meio adequado para uso em um, dispositivo eletrÈnico e dispositivo | |
GB0315450D0 (en) | Biological products | |
WO2005063820A3 (en) | Il-7 fusion proteins | |
DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
DK1572087T3 (da) | Antistoffer med cancerantigen TMEFF2 og anvendelser deraf | |
WO2004029072A3 (en) | PrPsc -INTERACTING MOLECULES AND USES THEREOF | |
EA200601191A1 (ru) | Продукты для ухода за ранами, содержащие кератин | |
PE20021098A1 (es) | ANTICUERPOS ESPECIFICOS DE CD44v6 | |
MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
WO2004081033A3 (en) | Synthesis of proteins by cell-free protein expression | |
GB0324656D0 (en) | A protein involved in ovarian cancer | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
ATE520711T1 (de) | Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten | |
ATE311456T1 (de) | Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln | |
WO2004031354A3 (en) | Human sarcoma-associated antigens | |
WO2004043397A3 (en) | Compositions and methods for the treatment of rheumatoid arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1427744 Country of ref document: EP |